

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | acrosome reaction (GO:0007340) | 5.85898371 |
| 2 | response to pheromone (GO:0019236) | 5.78166290 |
| 3 | sperm motility (GO:0030317) | 5.48683932 |
| 4 | fusion of sperm to egg plasma membrane (GO:0007342) | 5.19209692 |
| 5 | protein polyglutamylation (GO:0018095) | 4.54458977 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.48068438 |
| 7 | low-density lipoprotein particle clearance (GO:0034383) | 4.46765343 |
| 8 | plasma membrane fusion (GO:0045026) | 4.23654715 |
| 9 | single strand break repair (GO:0000012) | 4.22139905 |
| 10 | plasma lipoprotein particle clearance (GO:0034381) | 4.20572315 |
| 11 | alpha-linolenic acid metabolic process (GO:0036109) | 4.17464067 |
| 12 | protein carboxylation (GO:0018214) | 4.09344664 |
| 13 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.09344664 |
| 14 | rRNA methylation (GO:0031167) | 4.06213782 |
| 15 | regulation of cholesterol homeostasis (GO:2000188) | 4.05189090 |
| 16 | multicellular organism reproduction (GO:0032504) | 3.97488409 |
| 17 | negative regulation of fibrinolysis (GO:0051918) | 3.95922886 |
| 18 | spermatid development (GO:0007286) | 3.95888543 |
| 19 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.93465417 |
| 20 | L-phenylalanine metabolic process (GO:0006558) | 3.93465417 |
| 21 | regulation of cholesterol storage (GO:0010885) | 3.91840762 |
| 22 | urea cycle (GO:0000050) | 3.89943895 |
| 23 | urea metabolic process (GO:0019627) | 3.89943895 |
| 24 | negative regulation of telomere maintenance (GO:0032205) | 3.87680298 |
| 25 | high-density lipoprotein particle remodeling (GO:0034375) | 3.78859967 |
| 26 | response to acidic pH (GO:0010447) | 3.77651576 |
| 27 | regulation of protein activation cascade (GO:2000257) | 3.72771630 |
| 28 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.71213653 |
| 29 | L-phenylalanine catabolic process (GO:0006559) | 3.71213653 |
| 30 | negative regulation of cholesterol transport (GO:0032375) | 3.61246475 |
| 31 | negative regulation of sterol transport (GO:0032372) | 3.61246475 |
| 32 | calcium ion-dependent exocytosis (GO:0017156) | 3.61151104 |
| 33 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.60199580 |
| 34 | rRNA modification (GO:0000154) | 3.58729374 |
| 35 | phospholipid homeostasis (GO:0055091) | 3.58393054 |
| 36 | kynurenine metabolic process (GO:0070189) | 3.58111893 |
| 37 | regulation of complement activation (GO:0030449) | 3.57889651 |
| 38 | glycine metabolic process (GO:0006544) | 3.57250230 |
| 39 | cellular ketone body metabolic process (GO:0046950) | 3.55802599 |
| 40 | platelet dense granule organization (GO:0060155) | 3.54760652 |
| 41 | sperm-egg recognition (GO:0035036) | 3.54735349 |
| 42 | sulfur amino acid catabolic process (GO:0000098) | 3.51753463 |
| 43 | macroautophagy (GO:0016236) | 3.49398576 |
| 44 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.49335232 |
| 45 | apoptotic cell clearance (GO:0043277) | 3.49325158 |
| 46 | complement activation, alternative pathway (GO:0006957) | 3.48447406 |
| 47 | reverse cholesterol transport (GO:0043691) | 3.47056674 |
| 48 | nitrogen cycle metabolic process (GO:0071941) | 3.43347773 |
| 49 | serine family amino acid catabolic process (GO:0009071) | 3.40118610 |
| 50 | lysine metabolic process (GO:0006553) | 3.38538058 |
| 51 | lysine catabolic process (GO:0006554) | 3.38538058 |
| 52 | cellular modified amino acid catabolic process (GO:0042219) | 3.37543250 |
| 53 | microtubule severing (GO:0051013) | 3.36251003 |
| 54 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.34683496 |
| 55 | * L-alpha-amino acid transmembrane transport (GO:1902475) | 3.34542512 |
| 56 | cysteine metabolic process (GO:0006534) | 3.32795523 |
| 57 | behavioral response to nicotine (GO:0035095) | 3.32316798 |
| 58 | cholesterol efflux (GO:0033344) | 3.32296120 |
| 59 | glyoxylate metabolic process (GO:0046487) | 3.31241797 |
| 60 | aromatic amino acid family catabolic process (GO:0009074) | 3.29679007 |
| 61 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 3.28214900 |
| 62 | cellular response to pH (GO:0071467) | 3.25075330 |
| 63 | regulation of fibrinolysis (GO:0051917) | 3.24594164 |
| 64 | homocysteine metabolic process (GO:0050667) | 3.23358215 |
| 65 | mannose metabolic process (GO:0006013) | 3.23174275 |
| 66 | reproduction (GO:0000003) | 3.23138686 |
| 67 | regulation of cilium movement (GO:0003352) | 3.21217448 |
| 68 | phosphatidylethanolamine metabolic process (GO:0046337) | 3.20787223 |
| 69 | bile acid biosynthetic process (GO:0006699) | 3.20656089 |
| 70 | positive regulation by symbiont of host defense response (GO:0052509) | 3.19481178 |
| 71 | modulation by symbiont of host defense response (GO:0052031) | 3.19481178 |
| 72 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.19481178 |
| 73 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.19481178 |
| 74 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.19481178 |
| 75 | modulation by symbiont of host immune response (GO:0052553) | 3.19481178 |
| 76 | ketone body metabolic process (GO:1902224) | 3.18479795 |
| 77 | protein-lipid complex assembly (GO:0065005) | 3.17957826 |
| 78 | mannosylation (GO:0097502) | 3.16568374 |
| 79 | phospholipid efflux (GO:0033700) | 3.15635082 |
| 80 | plasma lipoprotein particle assembly (GO:0034377) | 3.11025189 |
| 81 | plasma lipoprotein particle remodeling (GO:0034369) | 3.08517958 |
| 82 | protein-lipid complex remodeling (GO:0034368) | 3.08517958 |
| 83 | macromolecular complex remodeling (GO:0034367) | 3.08517958 |
| 84 | 4-hydroxyproline metabolic process (GO:0019471) | 3.07011582 |
| 85 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.06264613 |
| 86 | negative regulation of Rho protein signal transduction (GO:0035024) | 3.05670811 |
| 87 | cellular biogenic amine catabolic process (GO:0042402) | 3.02648836 |
| 88 | amine catabolic process (GO:0009310) | 3.02648836 |
| 89 | response to pH (GO:0009268) | 3.00957203 |
| 90 | coenzyme catabolic process (GO:0009109) | 3.00025565 |
| 91 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.98546126 |
| 92 | glycerophospholipid catabolic process (GO:0046475) | 2.97340816 |
| 93 | amino-acid betaine metabolic process (GO:0006577) | 2.96635526 |
| 94 | regulation of microtubule-based movement (GO:0060632) | 2.96444336 |
| 95 | positive regulation of lipid catabolic process (GO:0050996) | 2.95721427 |
| 96 | regulation of cholesterol esterification (GO:0010872) | 2.94370277 |
| 97 | N-acetylneuraminate metabolic process (GO:0006054) | 2.93722123 |
| 98 | tryptophan catabolic process (GO:0006569) | 2.93605369 |
| 99 | indole-containing compound catabolic process (GO:0042436) | 2.93605369 |
| 100 | indolalkylamine catabolic process (GO:0046218) | 2.93605369 |
| 101 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.93206979 |
| 102 | positive regulation of lipid storage (GO:0010884) | 2.91439844 |
| 103 | acylglycerol homeostasis (GO:0055090) | 2.91250505 |
| 104 | triglyceride homeostasis (GO:0070328) | 2.91250505 |
| 105 | serine family amino acid metabolic process (GO:0009069) | 2.90383284 |
| 106 | tryptophan metabolic process (GO:0006568) | 2.90025921 |
| 107 | lipoprotein metabolic process (GO:0042157) | 2.89115566 |
| 108 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.88844532 |
| 109 | folic acid metabolic process (GO:0046655) | 2.88273515 |
| 110 | lytic vacuole organization (GO:0080171) | 2.87505631 |
| 111 | lysosome organization (GO:0007040) | 2.87505631 |
| 112 | bile acid metabolic process (GO:0008206) | 2.86657604 |
| 113 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.85697098 |
| 114 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.85225266 |
| 115 | serine family amino acid biosynthetic process (GO:0009070) | 2.85212285 |
| 116 | regulation of translational fidelity (GO:0006450) | 2.81793771 |
| 117 | amino sugar catabolic process (GO:0046348) | 2.81714420 |
| 118 | regulation of triglyceride catabolic process (GO:0010896) | 2.78820214 |
| 119 | negative regulation of lipid transport (GO:0032369) | 2.78055376 |
| 120 | glutamate metabolic process (GO:0006536) | 2.76996399 |
| 121 | binding of sperm to zona pellucida (GO:0007339) | 2.76598715 |
| 122 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.76316770 |
| 123 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.76316770 |
| 124 | cofactor catabolic process (GO:0051187) | 2.75952616 |
| 125 | positive regulation of fatty acid oxidation (GO:0046321) | 2.75824960 |
| 126 | basement membrane organization (GO:0071711) | 2.74468225 |
| 127 | 2-oxoglutarate metabolic process (GO:0006103) | 2.74399789 |
| 128 | sperm capacitation (GO:0048240) | 2.73929640 |
| 129 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.73006993 |
| 130 | protein-cofactor linkage (GO:0018065) | 2.72601828 |
| 131 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.72346082 |
| 132 | macrophage activation involved in immune response (GO:0002281) | 2.71958727 |
| 133 | fibrinolysis (GO:0042730) | 2.71856244 |
| 134 | negative regulation of cell size (GO:0045792) | 2.70851874 |
| 135 | cholesterol homeostasis (GO:0042632) | 2.70835121 |
| 136 | sterol homeostasis (GO:0055092) | 2.70724533 |
| 137 | protein localization to cilium (GO:0061512) | 2.70077262 |
| 138 | NAD biosynthetic process (GO:0009435) | 2.68679246 |
| 139 | cell-cell recognition (GO:0009988) | 2.67796298 |
| 140 | alpha-amino acid catabolic process (GO:1901606) | 2.67749231 |
| 141 | seminiferous tubule development (GO:0072520) | 2.67659113 |
| 142 | protein-lipid complex subunit organization (GO:0071825) | 2.67614440 |
| 143 | cell junction maintenance (GO:0034331) | 2.67172338 |
| 144 | gamma-aminobutyric acid transport (GO:0015812) | 2.65829044 |
| 145 | regulation of early endosome to late endosome transport (GO:2000641) | 2.65696013 |
| 146 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.64433050 |
| 147 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.64262452 |
| 148 | one-carbon metabolic process (GO:0006730) | 2.63904173 |
| 149 | positive regulation of action potential (GO:0045760) | 2.63208159 |
| 150 | positive regulation of prostaglandin secretion (GO:0032308) | 2.62449738 |
| 151 | spermatogenesis (GO:0007283) | 2.61100195 |
| 152 | male gamete generation (GO:0048232) | 2.60545480 |
| 153 | plasma lipoprotein particle organization (GO:0071827) | 2.60317579 |
| 154 | organic cation transport (GO:0015695) | 2.60222256 |
| 155 | nucleoside transmembrane transport (GO:1901642) | 2.57439964 |
| 156 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.57437919 |
| 157 | positive regulation of mitochondrial fission (GO:0090141) | 2.56715653 |
| 158 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.56315373 |
| 159 | cellular response to ATP (GO:0071318) | 2.54714920 |
| 160 | single fertilization (GO:0007338) | 2.52815626 |
| 161 | * alanine transport (GO:0032328) | 2.51795472 |
| 162 | L-serine metabolic process (GO:0006563) | 2.49011637 |
| 163 | epithelial cilium movement (GO:0003351) | 2.48347837 |
| 164 | regulation of telomere maintenance (GO:0032204) | 2.47544741 |
| 165 | peptidyl-glutamic acid modification (GO:0018200) | 2.44284689 |
| 166 | positive regulation of Rab GTPase activity (GO:0032851) | 2.44170904 |
| 167 | regulation of Rab GTPase activity (GO:0032313) | 2.44170904 |
| 168 | C-terminal protein lipidation (GO:0006501) | 2.44078530 |
| 169 | lymphangiogenesis (GO:0001946) | 2.43562562 |
| 170 | short-term memory (GO:0007614) | 2.43125925 |
| 171 | ubiquinone metabolic process (GO:0006743) | 2.43116008 |
| 172 | nephron tubule morphogenesis (GO:0072078) | 2.42360696 |
| 173 | nephron epithelium morphogenesis (GO:0072088) | 2.42360696 |
| 174 | tooth mineralization (GO:0034505) | 2.41888147 |
| 175 | axoneme assembly (GO:0035082) | 2.41639352 |
| 176 | protein localization to Golgi apparatus (GO:0034067) | 2.41495386 |
| 177 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.40750619 |
| 178 | intracellular pH reduction (GO:0051452) | 2.40391801 |
| 179 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.39718680 |
| 180 | gamete generation (GO:0007276) | 2.39266983 |
| 181 | establishment of protein localization to Golgi (GO:0072600) | 2.38603070 |
| 182 | arginine catabolic process (GO:0006527) | 2.38326795 |
| 183 | negative regulation of mast cell activation (GO:0033004) | 2.36653897 |
| 184 | polyamine biosynthetic process (GO:0006596) | 2.33616164 |
| 185 | proline transport (GO:0015824) | 2.31613737 |
| 186 | protein targeting to Golgi (GO:0000042) | 2.29573833 |
| 187 | * basic amino acid transport (GO:0015802) | 2.29248115 |
| 188 | aspartate family amino acid catabolic process (GO:0009068) | 2.29207355 |
| 189 | ubiquinone biosynthetic process (GO:0006744) | 2.28829232 |
| 190 | multicellular organismal movement (GO:0050879) | 2.28416940 |
| 191 | musculoskeletal movement (GO:0050881) | 2.28416940 |
| 192 | indolalkylamine metabolic process (GO:0006586) | 2.26790389 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.58505507 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.97857486 |
| 3 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.86427966 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.70556015 |
| 5 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 3.44354165 |
| 6 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.11639346 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.10016444 |
| 8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.03184375 |
| 9 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.00641639 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.72042186 |
| 11 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.47420493 |
| 12 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.34728952 |
| 13 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.28955552 |
| 14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.26324307 |
| 15 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.16298976 |
| 16 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.15170301 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.08766832 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.08608370 |
| 19 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.05738494 |
| 20 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.05225240 |
| 21 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.98044503 |
| 22 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.96826876 |
| 23 | MYC_22102868_ChIP-Seq_BL_Human | 1.96548308 |
| 24 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.90525639 |
| 25 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.87630185 |
| 26 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.85111588 |
| 27 | ERA_21632823_ChIP-Seq_H3396_Human | 1.82439064 |
| 28 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.81449207 |
| 29 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.79145814 |
| 30 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.78763235 |
| 31 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.78570471 |
| 32 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.78270592 |
| 33 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.73838656 |
| 34 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.73584228 |
| 35 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.72764426 |
| 36 | VDR_22108803_ChIP-Seq_LS180_Human | 1.72160581 |
| 37 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.70841182 |
| 38 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.68947978 |
| 39 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.68507226 |
| 40 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.67212951 |
| 41 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.67043578 |
| 42 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.66074481 |
| 43 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.65047408 |
| 44 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.63130025 |
| 45 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.62837193 |
| 46 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.59583987 |
| 47 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.59562745 |
| 48 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.58900334 |
| 49 | ATF3_27146783_Chip-Seq_COLON_Human | 1.58610837 |
| 50 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.58575659 |
| 51 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.55881427 |
| 52 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.55831716 |
| 53 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.55671339 |
| 54 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.55618574 |
| 55 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.55008023 |
| 56 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.53785957 |
| 57 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.53618325 |
| 58 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.53410337 |
| 59 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.53081162 |
| 60 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.52777252 |
| 61 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.51835293 |
| 62 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.49288088 |
| 63 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.49168737 |
| 64 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.49168737 |
| 65 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.47599560 |
| 66 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.46310635 |
| 67 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.44452457 |
| 68 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.42723567 |
| 69 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.42676412 |
| 70 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42108860 |
| 71 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.42045881 |
| 72 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.41415478 |
| 73 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.41066811 |
| 74 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.40000946 |
| 75 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.39078023 |
| 76 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.39005019 |
| 77 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.36988986 |
| 78 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.36587055 |
| 79 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.36345759 |
| 80 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.33424050 |
| 81 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.32874384 |
| 82 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.32489595 |
| 83 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.32342899 |
| 84 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.30602444 |
| 85 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.30406770 |
| 86 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.30353039 |
| 87 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.28572983 |
| 88 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.28221470 |
| 89 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.28049612 |
| 90 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.27662986 |
| 91 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.27480276 |
| 92 | * CBP_20019798_ChIP-Seq_JUKART_Human | 1.27480276 |
| 93 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.26993872 |
| 94 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.25908189 |
| 95 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.24908047 |
| 96 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.24470118 |
| 97 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.23638168 |
| 98 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.23511948 |
| 99 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.21883427 |
| 100 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.21731279 |
| 101 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.21483000 |
| 102 | P300_19829295_ChIP-Seq_ESCs_Human | 1.21218189 |
| 103 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.20947534 |
| 104 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.20556283 |
| 105 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.20347640 |
| 106 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.19152384 |
| 107 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.19038573 |
| 108 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.18990949 |
| 109 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.18831915 |
| 110 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.18730305 |
| 111 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.18729689 |
| 112 | AR_25329375_ChIP-Seq_VCAP_Human | 1.18317907 |
| 113 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18295252 |
| 114 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.17428872 |
| 115 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.17370318 |
| 116 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.17204944 |
| 117 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.17204944 |
| 118 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.17204944 |
| 119 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.17134640 |
| 120 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.15265028 |
| 121 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.14427447 |
| 122 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.13842471 |
| 123 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.12184884 |
| 124 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.11812857 |
| 125 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 1.11061121 |
| 126 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10777034 |
| 127 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.10604594 |
| 128 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.10537658 |
| 129 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.10141082 |
| 130 | KDM2B_26808549_Chip-Seq_K562_Human | 1.09232110 |
| 131 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08531079 |
| 132 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.07812917 |
| 133 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.07687083 |
| 134 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.07257330 |
| 135 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.06979396 |
| 136 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.06637269 |
| 137 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.06522352 |
| 138 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.06437030 |
| 139 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06383294 |
| 140 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.04567197 |
| 141 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.04390856 |
| 142 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03856956 |
| 143 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.02048767 |
| 144 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.01424598 |
| 145 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.99877624 |
| 146 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.99837767 |
| 147 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99767426 |
| 148 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.99576941 |
| 149 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.99425807 |
| 150 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.99026344 |
| 151 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.98593149 |
| 152 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.98593149 |
| 153 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.97954106 |
| 154 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.97870594 |
| 155 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.97480993 |
| 156 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.96941314 |
| 157 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.96593572 |
| 158 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.96322432 |
| 159 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.96259421 |
| 160 | * TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.95605598 |
| 161 | P68_20966046_ChIP-Seq_HELA_Human | 0.95308858 |
| 162 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.94950334 |
| 163 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.94934622 |
| 164 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94091517 |
| 165 | SPI1_23127762_ChIP-Seq_K562_Human | 0.93869143 |
| 166 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.93540716 |
| 167 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.93214634 |
| 168 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.93175062 |
| 169 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.92947401 |
| 170 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.92751877 |
| 171 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.92248871 |
| 172 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.91471054 |
| 173 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.91041579 |
| 174 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.90857176 |
| 175 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.90460161 |
| 176 | MAF_26560356_Chip-Seq_TH1_Human | 0.89755675 |
| 177 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.89728294 |
| 178 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.89728294 |
| 179 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.89508334 |
| 180 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.89426596 |
| 181 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.89213049 |
| 182 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.89047438 |
| 183 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.88514919 |
| 184 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.88472329 |
| 185 | PPARD_21283829_ChIP-Seq_MYOFIBROBLAST_Human | 0.87916238 |
| 186 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.87640818 |
| 187 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.87388828 |
| 188 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.86755376 |
| 189 | * NCOR_22424771_ChIP-Seq_293T_Human | 0.86514005 |
| 190 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.86449505 |
| 191 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.84839067 |
| 192 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.84811486 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005410_abnormal_fertilization | 5.33864682 |
| 2 | MP0009840_abnormal_foam_cell | 4.79406985 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 4.66171982 |
| 4 | MP0005360_urolithiasis | 3.97960204 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 3.85291047 |
| 6 | MP0005058_abnormal_lysosome_morphology | 3.51832351 |
| 7 | MP0005365_abnormal_bile_salt | 3.29599455 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 3.21404687 |
| 9 | MP0003172_abnormal_lysosome_physiology | 3.17224030 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 2.97354576 |
| 11 | MP0008438_abnormal_cutaneous_collagen | 2.70693742 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.68631700 |
| 13 | MP0005083_abnormal_biliary_tract | 2.49664112 |
| 14 | MP0003878_abnormal_ear_physiology | 2.28465059 |
| 15 | MP0005377_hearing/vestibular/ear_phenot | 2.28465059 |
| 16 | MP0003646_muscle_fatigue | 2.27389087 |
| 17 | MP0010329_abnormal_lipoprotein_level | 2.25898482 |
| 18 | MP0003303_peritoneal_inflammation | 2.22018601 |
| 19 | MP0003011_delayed_dark_adaptation | 2.21195788 |
| 20 | MP0005167_abnormal_blood-brain_barrier | 2.19985263 |
| 21 | MP0008875_abnormal_xenobiotic_pharmacok | 2.17845998 |
| 22 | MP0000604_amyloidosis | 2.16956351 |
| 23 | MP0004858_abnormal_nervous_system | 2.16365402 |
| 24 | MP0004133_heterotaxia | 2.14473916 |
| 25 | MP0010386_abnormal_urinary_bladder | 2.09896571 |
| 26 | MP0010352_gastrointestinal_tract_polyps | 2.02728363 |
| 27 | MP0003252_abnormal_bile_duct | 2.00885454 |
| 28 | MP0002837_dystrophic_cardiac_calcinosis | 1.91864874 |
| 29 | MP0005076_abnormal_cell_differentiation | 1.84201029 |
| 30 | MP0000609_abnormal_liver_physiology | 1.77350410 |
| 31 | MP0003566_abnormal_cell_adhesion | 1.75132504 |
| 32 | MP0006082_CNS_inflammation | 1.71001455 |
| 33 | MP0002102_abnormal_ear_morphology | 1.63426483 |
| 34 | MP0005332_abnormal_amino_acid | 1.63170956 |
| 35 | MP0010307_abnormal_tumor_latency | 1.62622137 |
| 36 | MP0005595_abnormal_vascular_smooth | 1.61802449 |
| 37 | MP0000569_abnormal_digit_pigmentation | 1.61607675 |
| 38 | MP0003718_maternal_effect | 1.60758545 |
| 39 | MP0005670_abnormal_white_adipose | 1.60673744 |
| 40 | MP0006054_spinal_hemorrhage | 1.58092547 |
| 41 | MP0003698_abnormal_male_reproductive | 1.57789950 |
| 42 | MP0003436_decreased_susceptibility_to | 1.53966805 |
| 43 | MP0005023_abnormal_wound_healing | 1.52652680 |
| 44 | MP0000538_abnormal_urinary_bladder | 1.49969679 |
| 45 | MP0005551_abnormal_eye_electrophysiolog | 1.47052929 |
| 46 | MP0010368_abnormal_lymphatic_system | 1.46871456 |
| 47 | MP0009046_muscle_twitch | 1.46618192 |
| 48 | MP0005319_abnormal_enzyme/_coenzyme | 1.44544847 |
| 49 | MP0002138_abnormal_hepatobiliary_system | 1.42660015 |
| 50 | MP0003136_yellow_coat_color | 1.40288582 |
| 51 | MP0001968_abnormal_touch/_nociception | 1.40226033 |
| 52 | MP0003195_calcinosis | 1.40030728 |
| 53 | MP0003075_altered_response_to | 1.38177428 |
| 54 | MP0004510_myositis | 1.36664495 |
| 55 | MP0002118_abnormal_lipid_homeostasis | 1.31879452 |
| 56 | MP0002653_abnormal_ependyma_morphology | 1.27862849 |
| 57 | MP0003329_amyloid_beta_deposits | 1.27564773 |
| 58 | MP0001542_abnormal_bone_strength | 1.27444578 |
| 59 | MP0003300_gastrointestinal_ulcer | 1.26395872 |
| 60 | MP0000598_abnormal_liver_morphology | 1.26159844 |
| 61 | MP0005084_abnormal_gallbladder_morpholo | 1.26136835 |
| 62 | MP0005257_abnormal_intraocular_pressure | 1.25559795 |
| 63 | MP0005464_abnormal_platelet_physiology | 1.20912610 |
| 64 | MP0000049_abnormal_middle_ear | 1.20291204 |
| 65 | MP0004019_abnormal_vitamin_homeostasis | 1.19809447 |
| 66 | MP0004185_abnormal_adipocyte_glucose | 1.19414580 |
| 67 | MP0002234_abnormal_pharynx_morphology | 1.19313771 |
| 68 | MP0004233_abnormal_muscle_weight | 1.15338604 |
| 69 | MP0003186_abnormal_redox_activity | 1.12910894 |
| 70 | MP0004147_increased_porphyrin_level | 1.12501538 |
| 71 | MP0009764_decreased_sensitivity_to | 1.12432152 |
| 72 | MP0002282_abnormal_trachea_morphology | 1.11796601 |
| 73 | MP0002229_neurodegeneration | 1.11774053 |
| 74 | MP0000371_diluted_coat_color | 1.11574184 |
| 75 | MP0001915_intracranial_hemorrhage | 1.10959339 |
| 76 | MP0001929_abnormal_gametogenesis | 1.10563899 |
| 77 | MP0009745_abnormal_behavioral_response | 1.09103838 |
| 78 | MP0002736_abnormal_nociception_after | 1.08505217 |
| 79 | MP0001849_ear_inflammation | 1.07874958 |
| 80 | MP0001666_abnormal_nutrient_absorption | 1.04655559 |
| 81 | MP0003137_abnormal_impulse_conducting | 1.03908143 |
| 82 | MP0009278_abnormal_bone_marrow | 1.03882046 |
| 83 | MP0001905_abnormal_dopamine_level | 1.03597041 |
| 84 | MP0005379_endocrine/exocrine_gland_phen | 1.03050586 |
| 85 | MP0004130_abnormal_muscle_cell | 1.02913067 |
| 86 | MP0002269_muscular_atrophy | 1.02570181 |
| 87 | MP0002557_abnormal_social/conspecific_i | 1.02519785 |
| 88 | MP0005253_abnormal_eye_physiology | 1.02027912 |
| 89 | MP0001984_abnormal_olfaction | 1.01520513 |
| 90 | MP0002938_white_spotting | 1.01194763 |
| 91 | MP0002064_seizures | 1.00247827 |
| 92 | MP0006276_abnormal_autonomic_nervous | 0.99402622 |
| 93 | MP0002572_abnormal_emotion/affect_behav | 0.95739889 |
| 94 | MP0003279_aneurysm | 0.95678160 |
| 95 | MP0001324_abnormal_eye_pigmentation | 0.95584391 |
| 96 | MP0002272_abnormal_nervous_system | 0.94617238 |
| 97 | MP0003448_altered_tumor_morphology | 0.94295512 |
| 98 | MP0008961_abnormal_basal_metabolism | 0.94147030 |
| 99 | MP0009384_cardiac_valve_regurgitation | 0.92520345 |
| 100 | MP0002733_abnormal_thermal_nociception | 0.92194463 |
| 101 | MP0002161_abnormal_fertility/fecundity | 0.91595437 |
| 102 | MP0003122_maternal_imprinting | 0.90272705 |
| 103 | MP0001970_abnormal_pain_threshold | 0.90267650 |
| 104 | MP0001529_abnormal_vocalization | 0.89718785 |
| 105 | MP0000858_altered_metastatic_potential | 0.89427429 |
| 106 | MP0009643_abnormal_urine_homeostasis | 0.88574464 |
| 107 | MP0001756_abnormal_urination | 0.88467631 |
| 108 | MP0003880_abnormal_central_pattern | 0.87211628 |
| 109 | MP0005666_abnormal_adipose_tissue | 0.86722395 |
| 110 | MP0000026_abnormal_inner_ear | 0.86149990 |
| 111 | MP0001533_abnormal_skeleton_physiology | 0.85748875 |
| 112 | MP0004272_abnormal_basement_membrane | 0.83968231 |
| 113 | MP0009763_increased_sensitivity_to | 0.83089254 |
| 114 | MP0005275_abnormal_skin_tensile | 0.82720620 |
| 115 | MP0001485_abnormal_pinna_reflex | 0.81720236 |
| 116 | MP0005166_decreased_susceptibility_to | 0.81681905 |
| 117 | MP0006072_abnormal_retinal_apoptosis | 0.81505114 |
| 118 | MP0003091_abnormal_cell_migration | 0.81230215 |
| 119 | MP0001963_abnormal_hearing_physiology | 0.81196247 |
| 120 | MP0002877_abnormal_melanocyte_morpholog | 0.80610541 |
| 121 | MP0002419_abnormal_innate_immunity | 0.80502350 |
| 122 | MP0004947_skin_inflammation | 0.80151608 |
| 123 | MP0001958_emphysema | 0.79733101 |
| 124 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.79483183 |
| 125 | MP0004859_abnormal_synaptic_plasticity | 0.79422103 |
| 126 | MP0001486_abnormal_startle_reflex | 0.79420323 |
| 127 | MP0008469_abnormal_protein_level | 0.79399648 |
| 128 | MP0005195_abnormal_posterior_eye | 0.79259627 |
| 129 | MP0002089_abnormal_postnatal_growth/wei | 0.78869939 |
| 130 | MP0003656_abnormal_erythrocyte_physiolo | 0.78175406 |
| 131 | MP0000733_abnormal_muscle_development | 0.77473271 |
| 132 | MP0008877_abnormal_DNA_methylation | 0.76240983 |
| 133 | MP0003690_abnormal_glial_cell | 0.75738199 |
| 134 | MP0003635_abnormal_synaptic_transmissio | 0.75210048 |
| 135 | MP0002090_abnormal_vision | 0.73558111 |
| 136 | MP0004883_abnormal_blood_vessel | 0.73141006 |
| 137 | MP0002876_abnormal_thyroid_physiology | 0.72693751 |
| 138 | MP0000343_altered_response_to | 0.72390591 |
| 139 | MP0003221_abnormal_cardiomyocyte_apopto | 0.71783163 |
| 140 | MP0000015_abnormal_ear_pigmentation | 0.70174587 |
| 141 | MP0000230_abnormal_systemic_arterial | 0.69745134 |
| 142 | MP0000358_abnormal_cell_content/ | 0.69452952 |
| 143 | MP0003633_abnormal_nervous_system | 0.68721858 |
| 144 | MP0005508_abnormal_skeleton_morphology | 0.68569200 |
| 145 | MP0002168_other_aberrant_phenotype | 0.67756367 |
| 146 | MP0002135_abnormal_kidney_morphology | 0.66725369 |
| 147 | MP0002254_reproductive_system_inflammat | 0.66709239 |
| 148 | MP0008775_abnormal_heart_ventricle | 0.66400628 |
| 149 | MP0003283_abnormal_digestive_organ | 0.65694905 |
| 150 | MP0005197_abnormal_uvea_morphology | 0.65577148 |
| 151 | MP0005174_abnormal_tail_pigmentation | 0.65247317 |
| 152 | MP0002067_abnormal_sensory_capabilities | 0.65235200 |
| 153 | MP0002086_abnormal_extraembryonic_tissu | 0.65225037 |
| 154 | MP0000955_abnormal_spinal_cord | 0.65186656 |
| 155 | MP0005375_adipose_tissue_phenotype | 0.64994244 |
| 156 | MP0003632_abnormal_nervous_system | 0.63809069 |
| 157 | MP0001730_embryonic_growth_arrest | 0.62624762 |
| 158 | MP0002136_abnormal_kidney_physiology | 0.60936739 |
| 159 | MP0000747_muscle_weakness | 0.60144589 |
| 160 | MP0004197_abnormal_fetal_growth/weight/ | 0.59633319 |
| 161 | MP0005334_abnormal_fat_pad | 0.58646929 |
| 162 | MP0009642_abnormal_blood_homeostasis | 0.57674998 |
| 163 | MP0002295_abnormal_pulmonary_circulatio | 0.57332150 |
| 164 | MP0002088_abnormal_embryonic_growth/wei | 0.56049549 |
| 165 | MP0009672_abnormal_birth_weight | 0.55638937 |
| 166 | MP0002078_abnormal_glucose_homeostasis | 0.55549308 |
| 167 | MP0000249_abnormal_blood_vessel | 0.55343713 |
| 168 | MP0001672_abnormal_embryogenesis/_devel | 0.53997133 |
| 169 | MP0005380_embryogenesis_phenotype | 0.53997133 |
| 170 | MP0002998_abnormal_bone_remodeling | 0.53725259 |
| 171 | MP0005164_abnormal_response_to | 0.53588419 |
| 172 | MP0003984_embryonic_growth_retardation | 0.52281790 |
| 173 | MP0010234_abnormal_vibrissa_follicle | 0.52278600 |
| 174 | MP0001845_abnormal_inflammatory_respons | 0.50986465 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 4.43805067 |
| 2 | Deep venous thrombosis (HP:0002625) | 4.29392082 |
| 3 | Xanthomatosis (HP:0000991) | 4.03586929 |
| 4 | Complement deficiency (HP:0004431) | 3.90383006 |
| 5 | Increased cerebral lipofuscin (HP:0011813) | 3.81520442 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.74140521 |
| 7 | Severe visual impairment (HP:0001141) | 3.33819235 |
| 8 | Myocardial infarction (HP:0001658) | 3.26927175 |
| 9 | Abnormality of complement system (HP:0005339) | 3.20957240 |
| 10 | Hand muscle atrophy (HP:0009130) | 3.18177959 |
| 11 | Cerebral aneurysm (HP:0004944) | 3.12723289 |
| 12 | Intrahepatic cholestasis (HP:0001406) | 3.11303639 |
| 13 | Mucopolysacchariduria (HP:0008155) | 3.06745919 |
| 14 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.06745919 |
| 15 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.06662857 |
| 16 | Congenital stationary night blindness (HP:0007642) | 3.06595315 |
| 17 | Type II lissencephaly (HP:0007260) | 3.02758783 |
| 18 | Dysostosis multiplex (HP:0000943) | 3.02363641 |
| 19 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.01837729 |
| 20 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.01837729 |
| 21 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.01837729 |
| 22 | Glomerulonephritis (HP:0000099) | 2.99950608 |
| 23 | Hypobetalipoproteinemia (HP:0003563) | 2.98705762 |
| 24 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.98364558 |
| 25 | Protrusio acetabuli (HP:0003179) | 2.98273571 |
| 26 | Abnormality of glycolipid metabolism (HP:0010969) | 2.97514902 |
| 27 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.97514902 |
| 28 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.97514902 |
| 29 | Nephronophthisis (HP:0000090) | 2.97154065 |
| 30 | Distal upper limb amyotrophy (HP:0007149) | 2.96075037 |
| 31 | Upper limb amyotrophy (HP:0009129) | 2.96075037 |
| 32 | Chronic hepatic failure (HP:0100626) | 2.95325610 |
| 33 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.93124225 |
| 34 | Vacuolated lymphocytes (HP:0001922) | 2.86060432 |
| 35 | Upper motor neuron abnormality (HP:0002127) | 2.86056896 |
| 36 | Skin nodule (HP:0200036) | 2.85468316 |
| 37 | Hypoalphalipoproteinemia (HP:0003233) | 2.80093484 |
| 38 | Attenuation of retinal blood vessels (HP:0007843) | 2.77496130 |
| 39 | Cervical subluxation (HP:0003308) | 2.73600479 |
| 40 | Hyperlipoproteinemia (HP:0010980) | 2.72931102 |
| 41 | Hypolipoproteinemia (HP:0010981) | 2.70865054 |
| 42 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.69502259 |
| 43 | Mutism (HP:0002300) | 2.64343639 |
| 44 | Global brain atrophy (HP:0002283) | 2.62852522 |
| 45 | Abnormality of the Achilles tendon (HP:0005109) | 2.60750121 |
| 46 | Abnormality of midbrain morphology (HP:0002418) | 2.58946564 |
| 47 | Molar tooth sign on MRI (HP:0002419) | 2.58946564 |
| 48 | Pendular nystagmus (HP:0012043) | 2.58821941 |
| 49 | Pancreatic cysts (HP:0001737) | 2.54244000 |
| 50 | Spastic diplegia (HP:0001264) | 2.53981343 |
| 51 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.53864245 |
| 52 | Hyperammonemia (HP:0001987) | 2.52921869 |
| 53 | Abnormality of the lower motor neuron (HP:0002366) | 2.47521943 |
| 54 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.45929142 |
| 55 | Axonal loss (HP:0003447) | 2.45070608 |
| 56 | Polydipsia (HP:0001959) | 2.42923350 |
| 57 | Abnormal drinking behavior (HP:0030082) | 2.42923350 |
| 58 | Loss of speech (HP:0002371) | 2.38117382 |
| 59 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.37504466 |
| 60 | Generalized aminoaciduria (HP:0002909) | 2.36864607 |
| 61 | Pancreatic fibrosis (HP:0100732) | 2.36833128 |
| 62 | Abnormality of the common coagulation pathway (HP:0010990) | 2.35743565 |
| 63 | Mesangial abnormality (HP:0001966) | 2.35409848 |
| 64 | Achilles tendon contracture (HP:0001771) | 2.35105758 |
| 65 | Inability to walk (HP:0002540) | 2.35083490 |
| 66 | Vertebral compression fractures (HP:0002953) | 2.34599793 |
| 67 | Keratoconus (HP:0000563) | 2.34329540 |
| 68 | Increased corneal curvature (HP:0100692) | 2.34329540 |
| 69 | Hypercholesterolemia (HP:0003124) | 2.34056489 |
| 70 | Abnormal gallbladder physiology (HP:0012438) | 2.32919892 |
| 71 | Cholecystitis (HP:0001082) | 2.32919892 |
| 72 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.32790941 |
| 73 | Epidermoid cyst (HP:0200040) | 2.32276914 |
| 74 | Abnormality of dental color (HP:0011073) | 2.30469533 |
| 75 | Joint hemorrhage (HP:0005261) | 2.30444358 |
| 76 | Abolished electroretinogram (ERG) (HP:0000550) | 2.30184186 |
| 77 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.28764133 |
| 78 | Amelogenesis imperfecta (HP:0000705) | 2.27033241 |
| 79 | Abnormality of the renal medulla (HP:0100957) | 2.26654398 |
| 80 | Abnormal biliary tract physiology (HP:0012439) | 2.24414486 |
| 81 | Bile duct proliferation (HP:0001408) | 2.24414486 |
| 82 | Opisthotonus (HP:0002179) | 2.22665069 |
| 83 | Shallow orbits (HP:0000586) | 2.21555867 |
| 84 | Adactyly (HP:0009776) | 2.21159177 |
| 85 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.21120725 |
| 86 | Hyperventilation (HP:0002883) | 2.20252754 |
| 87 | Nephritis (HP:0000123) | 2.18078367 |
| 88 | Albinism (HP:0001022) | 2.17247834 |
| 89 | Polyuria (HP:0000103) | 2.16862413 |
| 90 | Cerebellar dysplasia (HP:0007033) | 2.16410132 |
| 91 | Prolonged partial thromboplastin time (HP:0003645) | 2.14569972 |
| 92 | Decreased central vision (HP:0007663) | 2.14081772 |
| 93 | Prolonged neonatal jaundice (HP:0006579) | 2.13995045 |
| 94 | Turricephaly (HP:0000262) | 2.12057490 |
| 95 | Cortical dysplasia (HP:0002539) | 2.11087948 |
| 96 | Polyphagia (HP:0002591) | 2.10757598 |
| 97 | Absent speech (HP:0001344) | 2.09990681 |
| 98 | Reticulocytosis (HP:0001923) | 2.07608773 |
| 99 | Esophageal varix (HP:0002040) | 2.07365869 |
| 100 | Abnormality of proline metabolism (HP:0010907) | 2.07220026 |
| 101 | Hydroxyprolinuria (HP:0003080) | 2.07220026 |
| 102 | Abnormal urine output (HP:0012590) | 2.06891408 |
| 103 | Esotropia (HP:0000565) | 2.06704546 |
| 104 | Abnormality of macular pigmentation (HP:0008002) | 2.04457656 |
| 105 | Asymmetric septal hypertrophy (HP:0001670) | 2.01220438 |
| 106 | Aneurysm (HP:0002617) | 2.00653328 |
| 107 | Ketosis (HP:0001946) | 2.00435528 |
| 108 | Abnormality of the motor neurons (HP:0002450) | 1.99613166 |
| 109 | Abnormal neuron morphology (HP:0012757) | 1.99613166 |
| 110 | Spastic tetraplegia (HP:0002510) | 1.95175056 |
| 111 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.94893658 |
| 112 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.94893658 |
| 113 | Abnormal protein glycosylation (HP:0012346) | 1.94893658 |
| 114 | Abnormal glycosylation (HP:0012345) | 1.94893658 |
| 115 | Premature rupture of membranes (HP:0001788) | 1.94670869 |
| 116 | Anterior segment dysgenesis (HP:0007700) | 1.93875127 |
| 117 | Recurrent corneal erosions (HP:0000495) | 1.93126532 |
| 118 | Hyperglycinemia (HP:0002154) | 1.89855012 |
| 119 | Abnormality of the intrinsic pathway (HP:0010989) | 1.89618825 |
| 120 | Mitral stenosis (HP:0001718) | 1.88762746 |
| 121 | Progressive inability to walk (HP:0002505) | 1.87251009 |
| 122 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.86472470 |
| 123 | Hyperglycinuria (HP:0003108) | 1.85842786 |
| 124 | Increased CSF protein (HP:0002922) | 1.85498329 |
| 125 | Hypoglycemic coma (HP:0001325) | 1.85178159 |
| 126 | Stage 5 chronic kidney disease (HP:0003774) | 1.84813007 |
| 127 | Disproportionate short-trunk short stature (HP:0003521) | 1.84438115 |
| 128 | Retinal atrophy (HP:0001105) | 1.84093352 |
| 129 | Pathologic fracture (HP:0002756) | 1.83471117 |
| 130 | Progressive cerebellar ataxia (HP:0002073) | 1.83173153 |
| 131 | True hermaphroditism (HP:0010459) | 1.82920913 |
| 132 | Amyloidosis (HP:0011034) | 1.82680874 |
| 133 | Clumsiness (HP:0002312) | 1.81771212 |
| 134 | Ankle contracture (HP:0006466) | 1.81517244 |
| 135 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.81346931 |
| 136 | Abnormality of nucleobase metabolism (HP:0010932) | 1.80928717 |
| 137 | Retinal dysplasia (HP:0007973) | 1.80818890 |
| 138 | Bulbous nose (HP:0000414) | 1.80588235 |
| 139 | Protuberant abdomen (HP:0001538) | 1.79494968 |
| 140 | Sensorimotor neuropathy (HP:0007141) | 1.79203951 |
| 141 | Severe muscular hypotonia (HP:0006829) | 1.79139241 |
| 142 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.78837479 |
| 143 | Abnormality of alanine metabolism (HP:0010916) | 1.78837479 |
| 144 | Hyperalaninemia (HP:0003348) | 1.78837479 |
| 145 | Occipital encephalocele (HP:0002085) | 1.78472148 |
| 146 | Congenital sensorineural hearing impairment (HP:0008527) | 1.77023270 |
| 147 | Personality changes (HP:0000751) | 1.76788558 |
| 148 | Pseudobulbar signs (HP:0002200) | 1.76321166 |
| 149 | Congenital hepatic fibrosis (HP:0002612) | 1.75147680 |
| 150 | Peripheral demyelination (HP:0011096) | 1.74629227 |
| 151 | Abnormality of the aortic arch (HP:0012303) | 1.74491514 |
| 152 | Mitral valve prolapse (HP:0001634) | 1.73321339 |
| 153 | Peritonitis (HP:0002586) | 1.73017490 |
| 154 | Tetraparesis (HP:0002273) | 1.72553135 |
| 155 | Disinhibition (HP:0000734) | 1.71081221 |
| 156 | Tubulointerstitial nephritis (HP:0001970) | 1.70667310 |
| 157 | Frequent falls (HP:0002359) | 1.70560253 |
| 158 | Cholelithiasis (HP:0001081) | 1.70317854 |
| 159 | Neurofibrillary tangles (HP:0002185) | 1.70316239 |
| 160 | Diminished motivation (HP:0000745) | 1.69633334 |
| 161 | Neuronal loss in central nervous system (HP:0002529) | 1.67805379 |
| 162 | Stroke (HP:0001297) | 1.67630440 |
| 163 | Apathy (HP:0000741) | 1.67443850 |
| 164 | Atrophic scars (HP:0001075) | 1.67384388 |
| 165 | Macular degeneration (HP:0000608) | 1.67148196 |
| 166 | Spastic paraparesis (HP:0002313) | 1.66862404 |
| 167 | Abnormal cartilage morphology (HP:0002763) | 1.65600978 |
| 168 | Lissencephaly (HP:0001339) | 1.65544488 |
| 169 | Cone-rod dystrophy (HP:0000548) | 1.65048712 |
| 170 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.65038859 |
| 171 | Abnormality of glycine metabolism (HP:0010895) | 1.65038859 |
| 172 | Long toe (HP:0010511) | 1.64252166 |
| 173 | Hypophosphatemic rickets (HP:0004912) | 1.64231753 |
| 174 | Abnormality of macrophages (HP:0004311) | 1.63981127 |
| 175 | Abnormality of the vertebral endplates (HP:0005106) | 1.63594213 |
| 176 | Agitation (HP:0000713) | 1.62411219 |
| 177 | Inappropriate behavior (HP:0000719) | 1.60601217 |
| 178 | Decreased subcutaneous fat (HP:0001002) | 1.60451649 |
| 179 | Humeroradial synostosis (HP:0003041) | 1.59932008 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.12420651 |
| 2 | ERN1 | 4.11927003 |
| 3 | PKN2 | 3.95234772 |
| 4 | MAP4K2 | 3.71451418 |
| 5 | TESK1 | 3.31072332 |
| 6 | ADRBK2 | 3.19509903 |
| 7 | INSRR | 2.63136384 |
| 8 | FRK | 2.52432956 |
| 9 | RIPK1 | 2.45517087 |
| 10 | NEK1 | 2.25137743 |
| 11 | MAP3K9 | 2.22355095 |
| 12 | WNK3 | 2.21792442 |
| 13 | CDK12 | 2.20998117 |
| 14 | EPHA2 | 2.16474022 |
| 15 | BCKDK | 2.14723399 |
| 16 | LATS2 | 2.08669614 |
| 17 | LIMK1 | 2.08349369 |
| 18 | PLK4 | 2.07496283 |
| 19 | CAMK1D | 2.00183009 |
| 20 | SCYL2 | 1.95992396 |
| 21 | PLK2 | 1.95718618 |
| 22 | FGFR4 | 1.91080785 |
| 23 | PTK6 | 1.85956969 |
| 24 | WNK4 | 1.85000247 |
| 25 | TIE1 | 1.84503835 |
| 26 | KSR2 | 1.83936504 |
| 27 | GRK1 | 1.83821353 |
| 28 | TTN | 1.77969560 |
| 29 | MAP2K6 | 1.77028900 |
| 30 | GRK7 | 1.76576595 |
| 31 | PDGFRA | 1.68323671 |
| 32 | SIK1 | 1.64657923 |
| 33 | BMPR1B | 1.64240857 |
| 34 | EEF2K | 1.58330647 |
| 35 | MAP3K10 | 1.53637450 |
| 36 | BMX | 1.52151159 |
| 37 | ACVR1B | 1.51346275 |
| 38 | TLK1 | 1.41118448 |
| 39 | DYRK2 | 1.39564330 |
| 40 | MAP2K7 | 1.35093413 |
| 41 | CSNK1G3 | 1.33016409 |
| 42 | MAP3K4 | 1.30934362 |
| 43 | CSNK1G2 | 1.30544516 |
| 44 | PIM2 | 1.29936568 |
| 45 | FLT3 | 1.28000388 |
| 46 | PRKCG | 1.27256432 |
| 47 | MTOR | 1.26531921 |
| 48 | EPHB2 | 1.24570811 |
| 49 | NUAK1 | 1.24037237 |
| 50 | DDR2 | 1.23543115 |
| 51 | ICK | 1.22751059 |
| 52 | MAPK13 | 1.22031416 |
| 53 | CAMKK1 | 1.21522272 |
| 54 | TBK1 | 1.21258421 |
| 55 | TRIM28 | 1.19633331 |
| 56 | CSNK1G1 | 1.19411060 |
| 57 | PAK6 | 1.17929421 |
| 58 | ALK | 1.17044031 |
| 59 | PAK4 | 1.15612340 |
| 60 | CAMK1G | 1.15557466 |
| 61 | PTK2 | 1.13817340 |
| 62 | DAPK2 | 1.11224561 |
| 63 | TGFBR1 | 1.11021773 |
| 64 | STK38 | 1.10893783 |
| 65 | TGFBR2 | 1.09480404 |
| 66 | DYRK3 | 1.09397370 |
| 67 | PNCK | 1.08611539 |
| 68 | PINK1 | 1.08485547 |
| 69 | CSNK1A1L | 1.07419947 |
| 70 | MUSK | 1.06445475 |
| 71 | PRKCE | 0.99126101 |
| 72 | PDK2 | 0.98760173 |
| 73 | TYK2 | 0.98697685 |
| 74 | TAOK1 | 0.97156855 |
| 75 | MAP3K11 | 0.94764142 |
| 76 | PRKD2 | 0.94289295 |
| 77 | NTRK1 | 0.92306349 |
| 78 | CASK | 0.91851027 |
| 79 | MAPKAPK3 | 0.88825032 |
| 80 | TESK2 | 0.88610884 |
| 81 | RET | 0.86542535 |
| 82 | TAOK2 | 0.83571852 |
| 83 | MAP3K8 | 0.82397653 |
| 84 | CDK6 | 0.82130276 |
| 85 | ABL2 | 0.81794779 |
| 86 | MAP2K1 | 0.80296670 |
| 87 | LRRK2 | 0.79666883 |
| 88 | ADRBK1 | 0.79235155 |
| 89 | TNIK | 0.78894870 |
| 90 | MAP3K13 | 0.78535649 |
| 91 | BLK | 0.77297546 |
| 92 | MAP3K3 | 0.77259792 |
| 93 | MATK | 0.76396829 |
| 94 | MAP2K3 | 0.74785052 |
| 95 | DAPK3 | 0.73815298 |
| 96 | JAK1 | 0.73481704 |
| 97 | RIPK4 | 0.72953386 |
| 98 | JAK2 | 0.70221195 |
| 99 | PTK2B | 0.69693068 |
| 100 | NEK2 | 0.67163551 |
| 101 | PRKCZ | 0.67007194 |
| 102 | PHKG2 | 0.66752309 |
| 103 | PHKG1 | 0.66752309 |
| 104 | PAK3 | 0.65210461 |
| 105 | CSF1R | 0.63170283 |
| 106 | STK10 | 0.62550654 |
| 107 | FER | 0.61280801 |
| 108 | PKN1 | 0.61082347 |
| 109 | CSK | 0.59589622 |
| 110 | NTRK3 | 0.58937320 |
| 111 | HCK | 0.57443737 |
| 112 | ERBB4 | 0.56731538 |
| 113 | PAK2 | 0.56222731 |
| 114 | MAPKAPK5 | 0.52051088 |
| 115 | STK38L | 0.52031418 |
| 116 | MAP3K1 | 0.52010630 |
| 117 | ZAP70 | 0.51955564 |
| 118 | MAP3K2 | 0.51041016 |
| 119 | ARAF | 0.50936063 |
| 120 | EGFR | 0.49331592 |
| 121 | CDK4 | 0.48925059 |
| 122 | CSNK1A1 | 0.48623702 |
| 123 | MAP3K7 | 0.48613902 |
| 124 | TYRO3 | 0.48540642 |
| 125 | CAMKK2 | 0.48474790 |
| 126 | VRK2 | 0.48101966 |
| 127 | MAP2K2 | 0.48035553 |
| 128 | NEK9 | 0.47913735 |
| 129 | MAPK15 | 0.47599416 |
| 130 | KIT | 0.47264580 |
| 131 | PDPK1 | 0.47255638 |
| 132 | RPS6KA4 | 0.46826478 |
| 133 | MOS | 0.46731353 |
| 134 | TAOK3 | 0.46658384 |
| 135 | EPHA3 | 0.46528240 |
| 136 | RPS6KA2 | 0.46428187 |
| 137 | CAMK1 | 0.46371353 |
| 138 | MAP3K5 | 0.46273634 |
| 139 | EPHB1 | 0.45716426 |
| 140 | MAPK11 | 0.45432247 |
| 141 | IKBKB | 0.44641913 |
| 142 | MET | 0.43293738 |
| 143 | PRKD3 | 0.42014415 |
| 144 | KDR | 0.41371728 |
| 145 | PRKAA2 | 0.40719791 |
| 146 | DAPK1 | 0.40315766 |
| 147 | PRKG2 | 0.39868721 |
| 148 | LATS1 | 0.39485176 |
| 149 | CAMK2A | 0.39131654 |
| 150 | CAMK4 | 0.39041922 |
| 151 | PRKG1 | 0.39041447 |
| 152 | RPS6KA6 | 0.39023382 |
| 153 | PIK3CG | 0.37566537 |
| 154 | IRAK3 | 0.37516272 |
| 155 | RPS6KB2 | 0.36741358 |
| 156 | MYLK | 0.35622362 |
| 157 | SIK2 | 0.35364420 |
| 158 | DYRK1B | 0.35265916 |
| 159 | MARK1 | 0.34411658 |
| 160 | AKT2 | 0.34363958 |
| 161 | ROCK1 | 0.34156715 |
| 162 | MST1R | 0.33702592 |
| 163 | FGFR1 | 0.33350778 |
| 164 | LMTK2 | 0.33053688 |
| 165 | CHUK | 0.32880521 |
| 166 | NME1 | 0.32685752 |
| 167 | PDK1 | 0.32282103 |
| 168 | GRK6 | 0.31978918 |
| 169 | PRKACA | 0.31467115 |
| 170 | PRKCI | 0.31200152 |
| 171 | MAP2K4 | 0.29950958 |
| 172 | PRKCA | 0.29406854 |
| 173 | STK16 | 0.29376335 |
| 174 | CDK3 | 0.28766571 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.16551731 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.52751820 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.23167888 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.08033470 |
| 5 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.00724873 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.69654672 |
| 7 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.62737596 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.58117095 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.50704541 |
| 10 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.48933367 |
| 11 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.48579520 |
| 12 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.37871967 |
| 13 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.27721393 |
| 14 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.18229668 |
| 15 | Lysosome_Homo sapiens_hsa04142 | 2.00165951 |
| 16 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.96016514 |
| 17 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.74184254 |
| 18 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.67668182 |
| 19 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.67208314 |
| 20 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.66309311 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.61657584 |
| 22 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.59605966 |
| 23 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.59145523 |
| 24 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.58905800 |
| 25 | Phototransduction_Homo sapiens_hsa04744 | 1.54085266 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.52639385 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.48883081 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.44665604 |
| 29 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.42612688 |
| 30 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.40597176 |
| 31 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.40208273 |
| 32 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.35768038 |
| 33 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.34482080 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.32068798 |
| 35 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.31459070 |
| 36 | Carbon metabolism_Homo sapiens_hsa01200 | 1.28179406 |
| 37 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.26771152 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.26498288 |
| 39 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.24370676 |
| 40 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.24169132 |
| 41 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.21154777 |
| 42 | Other glycan degradation_Homo sapiens_hsa00511 | 1.20807541 |
| 43 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.20270074 |
| 44 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.19792167 |
| 45 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.18076652 |
| 46 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.18002740 |
| 47 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.13174964 |
| 48 | Prion diseases_Homo sapiens_hsa05020 | 1.11189665 |
| 49 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.10677139 |
| 50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.09619050 |
| 51 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.07824888 |
| 52 | Lysine degradation_Homo sapiens_hsa00310 | 1.07503437 |
| 53 | Galactose metabolism_Homo sapiens_hsa00052 | 1.06369462 |
| 54 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.04693318 |
| 55 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.04612418 |
| 56 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.04288180 |
| 57 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.02037400 |
| 58 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.01294492 |
| 59 | Nicotine addiction_Homo sapiens_hsa05033 | 0.99721740 |
| 60 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.99398752 |
| 61 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.99123679 |
| 62 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.97521261 |
| 63 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.96704871 |
| 64 | Basal transcription factors_Homo sapiens_hsa03022 | 0.96236354 |
| 65 | RNA polymerase_Homo sapiens_hsa03020 | 0.92909595 |
| 66 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.88314797 |
| 67 | Peroxisome_Homo sapiens_hsa04146 | 0.87953106 |
| 68 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.87904862 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85876402 |
| 70 | Insulin resistance_Homo sapiens_hsa04931 | 0.82870237 |
| 71 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.79231268 |
| 72 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.78698543 |
| 73 | Metabolic pathways_Homo sapiens_hsa01100 | 0.78410628 |
| 74 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.77872709 |
| 75 | Taste transduction_Homo sapiens_hsa04742 | 0.76201545 |
| 76 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.76101475 |
| 77 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.72264633 |
| 78 | Bladder cancer_Homo sapiens_hsa05219 | 0.71827354 |
| 79 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.71537331 |
| 80 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.71464374 |
| 81 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.70931774 |
| 82 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.70654316 |
| 83 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.70504474 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.69554920 |
| 85 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.68694971 |
| 86 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.68388209 |
| 87 | Tuberculosis_Homo sapiens_hsa05152 | 0.68109437 |
| 88 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.68078446 |
| 89 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.67447728 |
| 90 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.66773699 |
| 91 | Legionellosis_Homo sapiens_hsa05134 | 0.65693850 |
| 92 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.65445467 |
| 93 | ABC transporters_Homo sapiens_hsa02010 | 0.65405743 |
| 94 | Mineral absorption_Homo sapiens_hsa04978 | 0.64982371 |
| 95 | Amoebiasis_Homo sapiens_hsa05146 | 0.64877917 |
| 96 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.64221409 |
| 97 | Olfactory transduction_Homo sapiens_hsa04740 | 0.63820205 |
| 98 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60410070 |
| 99 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.59622695 |
| 100 | Sulfur relay system_Homo sapiens_hsa04122 | 0.59349665 |
| 101 | Proteasome_Homo sapiens_hsa03050 | 0.58950855 |
| 102 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.57120440 |
| 103 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.56528769 |
| 104 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.55403802 |
| 105 | Phagosome_Homo sapiens_hsa04145 | 0.54939447 |
| 106 | GABAergic synapse_Homo sapiens_hsa04727 | 0.54759892 |
| 107 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.54641008 |
| 108 | Morphine addiction_Homo sapiens_hsa05032 | 0.54126536 |
| 109 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.53988242 |
| 110 | Protein export_Homo sapiens_hsa03060 | 0.53578414 |
| 111 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.53567910 |
| 112 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.52764193 |
| 113 | Histidine metabolism_Homo sapiens_hsa00340 | 0.52490842 |
| 114 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.52159226 |
| 115 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.52119948 |
| 116 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.50464060 |
| 117 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.50183309 |
| 118 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.49915073 |
| 119 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.49890369 |
| 120 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.49597932 |
| 121 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49276926 |
| 122 | Apoptosis_Homo sapiens_hsa04210 | 0.49250945 |
| 123 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48385150 |
| 124 | Leishmaniasis_Homo sapiens_hsa05140 | 0.48233532 |
| 125 | Parkinsons disease_Homo sapiens_hsa05012 | 0.47644704 |
| 126 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.45777155 |
| 127 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.45383630 |
| 128 | Huntingtons disease_Homo sapiens_hsa05016 | 0.44696395 |
| 129 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.44462169 |
| 130 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.43795882 |
| 131 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.43274648 |
| 132 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.42718016 |
| 133 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.42616606 |
| 134 | Glioma_Homo sapiens_hsa05214 | 0.42325939 |
| 135 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.41680661 |
| 136 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.40024331 |
| 137 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.39537716 |
| 138 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.39518178 |
| 139 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.37184104 |
| 140 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.36869463 |
| 141 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36303074 |
| 142 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.35530498 |
| 143 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.35368891 |
| 144 | Pertussis_Homo sapiens_hsa05133 | 0.35323649 |
| 145 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.34703086 |
| 146 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.34591574 |
| 147 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.32392705 |
| 148 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.32052996 |
| 149 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.31634841 |
| 150 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.31386995 |
| 151 | Retinol metabolism_Homo sapiens_hsa00830 | 0.31315470 |
| 152 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.29945843 |
| 153 | Endocytosis_Homo sapiens_hsa04144 | 0.28782027 |

